Literature DB >> 22937521

Different outcomes of serpiginous choroiditis with or without ocular and systemic treatment.

Zhong-Shan Chen1, Qin Ding, Yan-Ping Song, Li Zhu, Zhi-Jian Huang, Ming Yan.   

Abstract

Entities:  

Year:  2012        PMID： 22937521      PMCID： PMC3428557          DOI： 10.3980/j.issn.2222-3959.2012.04.26

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  12 in total

Review 1.  Serpiginous choroiditis.

Authors:  Wee-Kiak Lim; Ronald R Buggage; Robert B Nussenblatt
Journal:  Surv Ophthalmol       Date:  2005 May-Jun       Impact factor: 6.048

2.  Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease.

Authors:  Jennifer I Lim; Christina J Flaxel; Laurie LaBree
Journal:  Ann Acad Med Singapore       Date:  2006-03       Impact factor: 2.473

3.  Clinical profile, treatment, and visual outcome of serpiginous choroiditis.

Authors:  H Abrez; Jyotirmay Biswas; S Sudharshan
Journal:  Ocul Immunol Inflamm       Date:  2007 Jul-Aug       Impact factor: 3.070

4.  Infliximab in serpiginous choroiditis.

Authors:  Pascal Seve; Emeline Mennesson; Jean-Daniel Grange; Christiane Broussolle; Laurent Kodjikian
Journal:  Acta Ophthalmol       Date:  2010-12       Impact factor: 3.761

5.  Fundus autofluorescence in serpiginous choroiditis.

Authors:  Felice Cardillo Piccolino; Andrea Grosso; Elisa Savini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

6.  Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization.

Authors:  J S Wu; H Lewis; S L Fine; D A Grover; W R Green
Journal:  Retina       Date:  1989       Impact factor: 4.256

7.  Interferon alpha-2a treatment for serpiginous choroiditis.

Authors:  Güngör Sobaci; Zeki Bayraktar; Atilla Bayer
Journal:  Ocul Immunol Inflamm       Date:  2005-02       Impact factor: 3.070

8.  Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome.

Authors:  A A Araujo; A P Wells; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

9.  Macular serpiginous choroiditis.

Authors:  Dinesh K Sahu; Abdul Rawoof; B Sujatha
Journal:  Indian J Ophthalmol       Date:  2002-09       Impact factor: 1.848

10.  Immunological studies on serpiginous choroiditis.

Authors:  H Erkkilä; L Laatikainen; E Jokinen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.